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ABSTRACT
Objectives: Hypertension has been reported as one of the 
most important etiologic factors in cardiovascular 
disease. The objectives of this study were to investigate 
the effect of hypertension on neurocognitive functioning 
and quality of life.
Design: The study was cross sectional, and clinic based. 
The sample comprised of 50 adult Zambians aged 40-
65years. 
Main outcomes: The main outcomes were neurocogntive 
functioning and quality of life.
Measures: The measures used in this study were the 
Zambian neurobehavioral test battery as a measure of 
neuro cognitive functioning and the SF12 Health survey 
as a measure of quality of life.
Results: There was no significant difference in 
neuropsychological test performance on all the seven 
ability domains measured. On Global Deficit Scores 
impairment index, Chi square showed more impairment 
in the hypertensive group; however this was not 
statistically significant. Pearson's correlations test 
showed that at 0.05 sig. side effects correlated negatively 
with Physical functioning (r=0.593) and mental health 
(r=0.598) and at 0.01 sig. with vitality scale (r=0.6340 
and social functioning (r=0.618) of the SF12 health 
survey domains. 
Conclusion:  Quality of life seems to be more affected 
than neurocognitive functioning in the hypertensives in 
this study.
INTRODUCTION
Hypertension is an important etiologic factor in 
1cardiovascular disease . Hypertension can also affect 
neurocognitive functioning, and has been shown to cause 
changes in the domains of: executive functioning, 
2, 3, 4.memory, and psychomotor speed These cognitive 
effects, combined with side effects of medication, can 
(5).
negatively affect the quality of life 
The World Health Organisation criteria for hypertension 
is a blood pressure (BP) greater than or equal to 160/95 
mmHg or the JNC 7 (Joint National Committee on 
Prevention, Evaluation, and Treatment report, 1997) 
criteria of blood pressure (BP) greater than or equal to 
140/90 mmHg or self-reported use of antihypertensive 
7.drugs  This study aims at finding out the impact of 
hypertension on neurocognitive functioning.
Hypertension is termed as a silent killer mainly because 
8.when it is uncomplicated, it is usually asymptomatic  
Untreated hypertension affects neurocognitive 
functioning even before clinical manifestations of 
4.cerebrovascular disease are seen These effect of 
hypertension is seen as subtle deficits in many domains of 
4neuropsychological performance . The effect of 
hypertension on neurocognitive functioning remains 
4poorly understood .The mechanisms that lead to 
cognitive decline in hypertensives are not fully 
understood yet, however knowledge in this area of study is 
9on the rise .
Decline in cognitive functioning more often than not 
affects the quality of life. The affects are three fold. Firstly 
hypertension itself leads to a change in lifestyle as patients 
must take steps to try and control the blood pressure levels 
8. This usually means a change in diet (i.e. decrease salt 
intake), and an increase in physical activity, if it is not in 
the acute stage. Secondly, even in its uncomplicated form, 
hypertension may still cause a decline in some cognitive 
deficits. Thirdly, when lifestyle modifications are not 
enough to control the blood pressure levels, medication is 
usually prescribed depending on the severity of the 
condition. Medications that are commonly prescribed are 
8diuretics, adrenergic blockers, calcium blockers . Wenger 
(1988) confirmed that the side effects from these 
10.medications negatively impact the quality of life 
The increase in urbanisation, physical inactivity, poor 
diet being important factors has lead to a rise in 
prevalence rates of hypertension even in the developing 
world like Zambia.  This has lead to an increase in the 
burden of non communicable diseases such as 
hypertension yet little research is going on this area. 
Further more there is need to realise the neurocognitive 
effects that result from this condition and how together 
with the side effects of the medication this leads to a 
reduction in the quality of life. 
The objectives of this study were to investigate the effect 




This was a cross sectional clinic based study carried out 
on Zambian adult population.
Participants
The sample consisted of a total of 50 participants between 
the age of 40-65years recruited from selected urban and 
rural clinics under ministry of health. The first 36 
participants were sampled randomly as part of a larger 
study and the other 14 were sampled purposefully to 
make sure the two groups were matched on age and 
gender. Hence hypertensives were recruited after 
normotensives in order to match the sample by age and 
gender.
In this study a population aged 40-65 was sampled 
because of the positive correlation between age and blood 
pressure. The rise in the systolic blood pressure is quite 
considerable in adults and the diastolic blood pressure 
rises between 40 and 60 years and thereafter begins to 
9.drop 
MEASURES
1.  Blood Pressure
Blood pressure was measured for the purpose of 
screening using
2.  Neurobehavioral medical screen
This a standardised questionnaire in the Zambia 
Neurobehavioral test battery which systematically 
reviews past medical and neurological histories, review 
of systems, history of any current or past medications and 
 a mercury sphygmomanometer with the 
assistance of a nurse
their side effects .
3. Neurocognitive Assessment.   
The neurocognitive assessment was carried out using the 
Zambia Neurobehavioral test battery (Table 1) that 
consisted of tests of visual episodic memory, verbal 
episodic memory, fluency, abstraction/executive 
functions, attention/working memory, speed of 
information processing, and motor function. 
4.  SF 12 Health survey
The SF12 Health survey is a 12 item questionnaire that 
measures the quality of life in hypertensives.SF12 stands 
for Short-form 12-item. This is the form that has been 
shortened from original SF-36 which was developed in 
the United States to measure the quality of life 
specifically for hypertensive patients. The 8 domains it 
measures include physical functioning, role physical, 
bodily pain, general health, vitality, social functioning, 
role emotional and mental health. The SF-12 is a valid 
5measure of health related quality of life .
5.  Hypertension questionnaire
In addition participants filled in a questionnaire that was 
specifically designed for this study to capture information 
on the hypertension condition. The questions included 
information on the duration since diagnosed, medication, 
and its side effects and hence the side effect variable in the 
data management which is a continuous variable that 
includes responses on the questionnaire.
Procedure
The data for this study was collected as a part of a larger 
project of the Norad Masters Program. Recruitment of the 
participants was done by the clinic staff  from urban 
clinics in Lusaka district( Kalingalinga, UNZA, 
Mtendere, and Chilenje ) and rural clinics (Chibombo, 
Chongwe, and Kafue)  through the ongoing Voluntary 
Counselling and HIV testing campaign. HIV negative 
participants who were hypertensive (based on clinic 
records) and falling within the stated age range were 
given information about the study and requested to take 
part. Before the data collection the participants gave 
informed consent. The normotensives were also recruited 
through the ongoing HIV voluntary test campaign by the 
clinics staff in the various clinics mentioned above.
Before administering the Zambia Neurobehavioral test, 
blood pressure of the participants was measured with the 
help of a nurse; if it was found to be stable on the day of 
assessment (less than 180 systolic pressure and less than 
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110 diastolic pressure, WHO/ISH Classifications 
(1999),The Neurobehavioral medical screen was 
administered. If the participants were found 
neurologically normal, HIV negative and without a 
history of cardiac condition, thyroid disease, renal failure 
and diabetes mellitus  then the entire Zambia 
neurobehavioral test battery, the SF12 and the 
hypertension questionnaire was administered.
Table 1 : Zambia Neuropsychological Test Battery
Ethical Considerations
Approval was obtained from The University of Zambia 
Biomedical Research Ethics prior to the commencement 
of the research. We ensured confidentiality, voluntary 
participation, coding data such that during data 
management no names were used.
Data management and analysis 
The data was analysed using SPSS computer software 
(version 15,); t-test was carried out to compare the 
neurocognitive performance in hypertensives and 
normotensives on the seven ability domains of the NPS 
battery.
Hypertension status versus GDS impairment: The global 
deficit scores of hypertensives and normotensives were 
compared using chi-square test Individuals were 
considered impaired if they had a GDS of 0.5 or higher.
Pearson's correlation test was carried out to determine if 
there was any correlation between side effects variable 
and SF12 domains.
T scores corrected for age, education, rural/urban 
residence , was used for all analysis.
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The response rate was quite good; out of 50 participants 
we recruited 21 hypertensives and 29 normotensives
Characteristics of the participants
Hypertensives were slightly older than normotensives, 
P=0.195, while normotensives had a slightly higher mean 
education at P=0.309, however this was not statistically 
significant. Equal variances were assumed.
Neurocognitive performance
Neurocognitive performance of hypertensives and 
normotensives were compared on all the seven domains 
and from the mean scores, there were no statistically 
significant differences in performance between 
hypertensives and normotensives on the seven 
neuropsychological domains ps≥0.356).
Further analysis done to determine whether there was any 
significant difference in the global deficit score between 
the hypertensives and normotensives revealed that there 
was a higher percentage (14.3%) of impairment within the 
hypertensive group as compared to the normotensives 
2group (6.9%), however this finding was not significant (÷  
= 0.74, p=0.390).
Relationship between Quality of Life and side effects 
of medication.
Side effects of medication as determined by the 
hypertension questionnaire  were correlated with the 
SF12 scores and it was found that side effects of 
medication score negatively correlated with physical 
functioning(r=0.593) and mental health (r=0.598)vitality 
scale(r=0.634) and the social functioning(r=0.618).
Table 6 : Correlation table between side effects and Quality 
of life
*Correlation is significant at 0.05 level (2 tailed)
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DISCUSSION
The main objectives in this study were: To establish if 
there is there a significant difference in neurocognitive 
functioning between normotensives and hypertensives, 
and to determine if there is a relationship between side 
effects of medication for hypertension and the 
hypertensives' quality of life.
We found that there was no statistically significant 
differences in neurocognitive functioning between 
hypertensives and normotensives on the tests of attention, 
fluency, motor dexterity, visual episodic memory, verbal 
episodic memory, executive functioning. This result can 
be looked in the light of the argument by Blumenthal and 
M a d d e n  ( 1 9 8 9 )   t h a t  v a r i o u s  f o r m s  o f  
neuropsychological test batteries have revealed 
neuropsychological hypertension related deficits on 
some measures and it was not clear why such deficits 
13could appear on some tests and not on others . The 
present study was the first of its kind on this particular test 
battery; hence it could have been quite different from 
other test batteries used by other researchers. This is 
confirmed by Birns and Kalrd (2009). Consistent with the 
findings in this study, there are studies that have found no 
significant differences in performance between 
12; 15medicated hypertensives and normontensives .
The methodological control over confounding variables 
such as age, education, rural urban status, alcohol abuse, 
and concurrent medical condition could have been done 
differently from what other researchers in the past have 
done. Another factor which may have influenced the 
results is the fact that the study sampled well controlled 
hypertensives and this could suggest that the condition 
might be in its mild stage and medication could be acting 
as a neuroprotector on drastic cognitive decline. 
Variations have been noted in the stage of the condition, 
differences in medication ,as these form a separate entity 
14; 12on cognitive impairment . Variations in results have 
been noted with mild, moderate and severe hypertension. 
There are studies that have found no significant 
differences in performance between medicated 
hypertensives and normotensives. Paran, Anson, Reuveni 
(2003) further confirm this in their   study of blood 
16pressure among the elderly . They found that mild 
hypertension actually appeared to enhance cognitive 
functioning in their sampled population.
Further variations have been noted in studies that have 
sampled participants on different antihypertensive drugs 
14; 12as this form a separate entity on cognitive impairment .
On global deficit scores impairment, more impairment 
was noted in the hypertensive group than the 
normotensives group by 7.9%,however this was not 
significant,x2=0.74,P=0.390. 
The use of global deficit scores to predict impairment has 
been widely adopted by researchers to report impairment 
in different conditions (17). In 2010 Carey  et al. carried 
out a study to explore the predictive validity of the Global 
d e f i c i t  s c o r e  a p p r o a c h  i n  s u m m a r i s i n g  
neuropsychological test results, but their study was 
specifically in detecting HIV-related cognitive 
impairment. Their results supported the validity of the 
GDS as a clinically useful way of summarising 
11Neuropsychological test results . 
We found that an increase in the side effects of the 
medication led to poorer physical functioning, mental 
health, social functioning and vitality. Our finding is 
consistent with Wenger (1988) who documented the 
domains of daily life that are usually affected, among 
them was the side effects of the medication. Wenger 
(1988) in the study on the quality of life issues in 
hypertension documented the domains of daily life that 
are usually affected.  These include side effects of the 
medication, fatigue, libido levels, memory deficits, mood 
swings, alertness, sleep disorders, performance at work, 
and relations with family. 
In many cases treatment of chronic illnesses is not 
curative therefore it becomes imperative to improve 
functioning and quality of life (18). Nearly all anti 
hypertensive medication has been associated with some 
side effects (19). In the present study most participants 
were on diuretics. And Dimsdale (1992) confirms that 
even patients treated on diuretics commonly report side 
effects.
CONCLUSION 
As seen in the results of this study, hypertensives are 
affected not only by the disease itself but also by the side 
effects of the medication thereby markedly reducing their 
quality of life. Therefore, we can conclude that in our 
study population quality of life was more affected than 
neurocognitive functioning.
This may suggest the need for interventions to improve 
quality of life in hypertensive individuals. These are 
mainly life style modifications as supported by   Smith et 
al., (2010) who found that increased aerobic fitness and 
weight loss appeared to improve neurocognitive 
functioning (20).
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Strengths and Limitations of the study
Due to the non availability of CT and MRI scans in 
Zambia, this study did not have brain structure evidence in 
these participants.  Additionally, screening for a history 
and/or presence of co morbid conditions that occur with 
hypertension was not   done therefore we relied on 
participant's clinic record. 
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